XPlan

Company Overview

Snapshot

Founded in November 2023 by Moshe Safran and Ilya Kovler, XPlan operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-powered solutions for precision arthroplasty.

Business overview

XPlan specializes in developing AI-powered technology for precision arthroplasty, offering robust and highly accurate solutions for preoperative planning. The company's core technology leverages patent-pending innovations to generate 3D models directly from standard X-rays, eliminating the need for costly CT scans and manual 3D segmentation. XPlan serves the healthcare industry, particularly providers, by enabling advanced digital healthcare and medical decision support in orthopedics and surgery.

Company Intelligence Q&A

What is XPlan's primary focus?

XPlan's primary focus is on AI-powered precision arthroplasty, providing advanced solutions for preoperative planning in orthopedic surgery.

When was XPlan founded and by whom?

XPlan was founded in November 2023 by co-founders Moshe Safran and Ilya Kovler.

What problem does XPlan's technology address?

XPlan's technology addresses the need for accurate 3D modeling in preoperative planning without requiring expensive CT scans, by generating 3D models directly from standard X-rays using AI.

What is the current stage of XPlan's product development?

XPlan's product is currently in the R&D stage, focusing on developing its AI-based implant fitting and 2D to 3D reconstruction technologies.

Which industries or markets does XPlan serve?

XPlan serves the healthcare and life sciences sectors, specifically targeting healthcare providers with its medical decision support and digital healthcare solutions.